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Background: A great association between vitamin D deficiency and type 2 diabetes mellitus has been suggested
in literature. During pregnancy, this deficiency is even more critical. It appears that vitamin D insufficiency during
pregnancy may be associated with maternal hazards. The aim of this study was to assess the relation between the
levels of 25-hydroxy-cholecalciferol (vitamin D), and the glycemic control in pregnant women.
Methods: An observational cross-section study including 160 pregnant women between 20-40 years in age, in their
third trimester, divided into two equal groups. First group consisted of 80 women with established diagnosis of
gestational diabetes and the second group with proved normal blood glucose levels. We assessed vitamin D in serum,
fasting blood glucose, serum insulin and glycosylated hemoglobin (HbA1c) levels and we depicted the insulin sensitivity
using the Quantitative insulin sensitivity check index (Quicki). The results were collected and statistically correlated.
Results: The mean vitamin D levels were 46.61 ± 6.087 and 47.25 ± 10.181in controls and women with gestational
diabetes mellitus (GDM) respectively. The fasting insulin levels were significantly higher in the group with GDM with a
mean of 18.51 ± 6.44 compared to 8.95 ± 2.52 in the control group.
The correlation coefficient (r) between HbA1c levels and Vitamin D level was -0.492 with a P value <0.05. Similar
associations were also found with the fasting blood sugar levels (r = - 0.386) and with Quicki values (r = -0.250).
Vitamin D levels correlated significantly with the fasting blood glucose, the fasting serum insulin and the HbA1c
levels, the P value in all these correlations were <0.05. The P value with Quicki results was 0.064.
Conclusions: There is a statistically significant negative correlation between the glycemic control and vitamin D
levels in serum in the whole study population. The effect of adequate vitamin D replacement on glycemic
control was not studied in our work correlation. We suggest larger scale studies addressing this issue.
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Vitamin D acting on its own receptors can produce a
number of desired biological effects via different mecha-
nisms and, therefore, contributes to the improvement of
human health [1]. After absorption, vitamin D is bound to
the binding protein and carried to the liver via the blood-
stream. From there it begins two hydroxylation processes;* Correspondence: yahiaelfaissal@gmail.com
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min D (calcidiol), and finally, in the kidneys, where it is
transformed into 1,25 dihydroxy-vitamin D (calcitriol),
which is the biologically active form of vitamin D. The
levels of serum active vitamin D; 1,25dihydroxy-cholecal-
ciferol (1,25(OH)2 2D) increase during pregnancy as
depicted by several studies, the general conclusion
linked this serum rise to increased renal hydroxylation
of 25-hydroxy-cholecalciferol (25(OH) D) to 1,25(OH)2
2D under stimulation of pregnancy [2].Ltd. This is an Open Access article distributed under the terms of the Creative
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and type 2 diabetes mellitus [3]. In addition, some papers
reported a prevalence of inadequate 25(OH)D levels in
41% of the women with GDM, and they consequently pro-
posed routine 25(OH) D testing of all pregnant women
when screening for GDM or earlier, and treatment of
women who are found to be deficient [4].
This proposition was the rationale behind this study;
we found a need to study the status of vitamin D defi-
ciency amongst Egyptian females and its relation to the
glycemic control in pregnant women with GDM, and we
aimed at producing recommendations concerning this
issue to be implemented in the current Egyptian antenatal
care program.
We included in this study the assessment of the glycated
haemoglobin (HbA1c). The glycation of haemoglobin was
first used 25 years ago to assess the level of glycaemia in
subjects with diabetes [5]. Since then, assay of HbA1c has
become the ‘gold standard’ by which the effectiveness of
glycemic control is judged in clinical practice [6].
Aim of work
This study investigated the relation between vitamin D3
level and the glycemic control assessed by HbA1c, blood
glucose levels, Quicki and insulin in serum in gestational
diabetes mellitus.
Methods
This cross-sectional observational study was conducted
at Cairo University hospital; Kasr al-Aini, the obstetrics
and gynecology department, during the period between
June 2012 and June 2013. It was approved by the Scientific
& Ethical Committee of the Obstetrics and Gynecology
Department of Cairo University. We approached the preg-
nant women, in the third trimester, attending the antenatal
care clinic of Cairo university hospital during this period,
the target age group was between 20-40 years. We first
enrolled 80 pregnant women with established diagnosis
of gestational diabetes. Those women were diagnosed as
having GDM as depicted by estimating the fasting and 2-
hours post-prandial blood glucose levels in previous ante-
natal care visit; they were already receiving treatment for
their condition, through a collaborative approach, involv-
ing the Diabetes Mellitus outpatient clinic and the internal
medicine department of Cairo University. We then in-
cluded a second group; consisting of randomly selected 80
pregnant women, those women had normal fasting and 2-
hours post-prandial blood glucose levels blood glucose
levels, during their routine antenatal care visits. The need
to include a control group emerged when we were faced
by the high incidence of vitamin D deficiency among our
included cases of the first group. A question was raised; is
this deficiency caused by impaired glucose tolerance, or it
is a common finding in the population study. We includedan equal number to the previously enrolled pregnant dia-
betic women, in order to obtain statistical equality. Written
Informed consents were obtained from each participant
prior to enrollment; the consent form was written in Arabic
language and followed the world health organization guide-
lines (WHO). All consent forms were signed by one of the
investigators, and were collected and filed. Patients giving
history of type 1 or 2 diabetes mellitus antedating preg-
nancy were excluded, as well as any medical disorders (such
as hypertension or cardiac disease) or medical complica-
tions related to pregnancy. All the patients included
were subjected to detailed history taking with special
focus on maternal age, parity, gestational age at diagno-
sis of gestational diabetes, previous history or family his-
tory of diabetes, history of gestational diabetes in previous
pregnancies. Data concerning insulin regimens, insulin
types and doses (if diagnosed of having gestational dia-
betes) were also noted. Body Mass Index (BMI) was calcu-
lated for all subjects as follows; weight in kilograms
divided by their height in meters squared (18.5 or less:
underweight, 18.5-24.9 is normal, 25-29.9: overweight, 30-
39.9: Obese and 40 or greater is extremely obese). The
BMI in the control group was matched to that in the
GDM group for sakes of statistical adjustment. Laboratory
investigation included Vitamin D3 level measured by radio
immunoassay. Vitamin D deficiency was defined conserva-
tively as <25 ɳmol/L, insufficiency as 25–50 ɳmol/L and
sufficiency as >50 ɳmol/L. HbA1c was measured by radio-
immunoassay to assess the glycemic control. The normal
level for glycosylated hemoglobin is less than 7%. Diabetics
rarely achieve such levels, but tight control aims to come
close to it. Levels above 9% show poor control, and levels
above 12% show very poor control. Fasting serum insulin
(in mIU/L), fasting blood glucose and 2 hours postprandial,
interpreted in mg/dL were included within the laboratory
investigations. The insulin sensitivity as a reflection of insu-
lin resistance was measured using the Quantitative insulin
sensitivity check index (Quicki). This index correlates well
with glucose clamp studies (r =0.78), and it has the advan-
tage of that it can be obtained from a fasting blood sample,
hence it is the preferred method for several types of clinical
research [7]. It is calculated as {1/( log fasting insulin +
log fasting blood sugar). Blood samples were collected from
pregnant women with gestational diabetes during preg-
nancy during routine antenatal care visits and were ana-
lyzed in Cairo University Clinical Pathology Department’s
laboratories. All results were statistically analyzed and
tabulated.
Statistical analysis
Data were statistically described in terms of mean ± stand-
ard deviation (±SD), median and range, or frequencies
(number of cases) and percentages when appropriate. Com-
parison of numerical variables between the study groups
Table 1 Clinical and biochemical demographic data of the studied groups
Controls (n = 80) Cases with GDM (n = 80) P-value
Maternal age in years 24.40 +/- 3.77 25.38 +/- 3.83 0.107 (NS)
Pre-pregnancy BMI (Kg/m2) 25.31 +/- 2.39 26.46 +/- 2.95 0.665 (NS)
Parity 1.79 +/- 1.06 1.81 +/- 1.02 0.88 (NS)
Previous history of GDM 5 (6.25%) 29 (36.25%) 0.0001(S)
Family history of type 2 DM 9 (11.25%) 36 (45%) 0.0001(S)
Fasting blood sugar mg/dl 77.05 +/- 7.15 94.05 +/- 14.33 0.000 (S)
25OHD (nmol/L) 46.61 +/- 6.08 47.25 +/- 10.18 0.632 (NS)
HbA1C 4.47 +/- 0.54 4.25 +/- 1.09 0.117 (NS)
Fasting insulin 8.95 +/- 2.52 18.51 +/- 6.44 0.000 (S)
Quicki 0.3518 +/- 0.1784 0.4848 +/- 0.0195 0.000 (S)
25OHD: 25-hydroxyvitamin D, BMI: body mass index, DM: diabetes mellitus, GDM: gestational diabetes mellitus, NS: not significant, S:significant, OGTT: oral glucose
tolerance test, PGL:plasma glucose.
Table 2 The correlation between HbA1C and different





Fasting blood sugar - 0.386 0.000 S
Fasting insulin levels 0.332 0.000 S
Vitamin D levels −0.492 0.000 S
QUICKI equation −0.250 0.001 S
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comparing categorical data, Chi square test was performed.
Exact test was used instead when the expected frequency is
less than 5. P values less than 0.05 was considered statisti-
cally significant. All statistical calculations were done using
computer programs SPSS (Statistical Package for the Social
Science; SPSS Inc., Chicago, IL, USA) version 15 for Micro-
soft Windows.
Results
One hundred and sixty pregnant women, in their third tri-
mester, consented to participate in this study. They were
all comparable regarding the maternal age, pre-pregnancy
body mass index (BMI), and parity as shown in Table 1.
The fasting plasma glucose level was significantly lower in
controls compared to those with gestational diabetes.
36.25% of cases with gestational diabetes gave history of
GDM in previous pregnancies which was also statistically
significant (p-value = 0.0001), also family history of type 2
DM seemed more likely in this same group. The majority
of the controls and women with GDM suffered from Vita-
min D insufficiency rather than deficiency where the mean
25 OHD levels were 46.61 ± 6.087 and 47.25 ± 10.181 re-
spectively. The fasting insulin levels were significantly
higher in the group with GDM with a mean of 18.51 ±
6.44 compared to 8.95 ± 2.52 in the control group.
A significant inverse correlation was found between the
HbA1C levels and Vitamin D levels (correlation coefficient
r = -0.492, P value <0.05 ), where the higher the levels of
Vitamin D, the lower the HbA1c levels indicating a good
glycemic control in women with gestational diabetes. An
inverse association was also found with the fasting blood
sugar levels which was statistically significant (the correl-
ation coefficient r = - 0.386), as well as with Quicki values
(r = - 0.250) (Table 2).
As regards the Vitamin D levels, Table 3 shows that
they negatively correlated with the fasting blood glucoselevels (Figure 1), the fasting serum insulin levels and the
HbA1c levels, in the whole study population including
both groups; women with GDM and controls. The P
value in all these correlations were <0.05. The Quicki
values, however, did not significantly correlate with the
Vitamin D levels, the P value being 0.064.
Discussion
Vitamin D plays a great role in bone metabolism and
mineral homeostasis. Relevant data identify roles for the
active form of vitamin D (1,25(OH)2D3) in many bio-
logical processes including regulation of cellular growth,
differentiation and metabolic modulations [8]. Vitamin
D insufficiency has a known effect on bone density, neo-
natal vitamin D and calcium status, and childhood rick-
ets [9]. In several studies, the relation between low
vitamin D levels, insulin resistance and impaired insulin
secretion was clearly demonstrated [10]. Moreover, spe-
cific receptors for 1,25(OH)2D3 were detected in pan-
creatic ß cells, denoting a probable effect of vitamin D on
the insulin secretion process [11]. Obesity is another sig-
nificant risk factor for 25OHD deficiency [12,13]. An ana-
lysis of the National Health and Nutrition Examination
Survey (NHANES) for the years 2003/2004 data also dem-
onstrated that 25 (OH) D deficiencies were highly preva-
lent in overweight and obese American subjects [14].
Table 3 The correlation between the Vitamin D levels and
the various maternal biochemical variables in women




Fasting blood sugar −0.245 0.000 S
Fasting insulin levels −0.357 0.000 S
HbA1C levels −0.492 0.000 S
Quicki equation 0.147 0.064 NS
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cemic control and vitamin D deficiency in pregnant
women known to have gestational diabetes, diagnosed at
previous visits, and we included normal pregnant popula-
tion as a control. Vitamin D deficiency was the salient fea-
ture in both groups, with the mean serum vitamin D
levels close in both groups. This could be explained by the
fact that the great majority of the pregnant women, in-
cluded in our study, belonged to poor economic standards
which may affect a good supplementation of vitamin D;
they have poor housing conditions, poor exposure to sun,
insufficient food intake which might be referred to as
vegetarian in other papers, repeated non spaced pregnan-
cies and lack of medical service to provide good vitamin
supplementation. Another important factor is that, in spite
of the sunny climate in Egypt, all the included women
were veiled, which hinder the passage of sunrays to the
skin, and subsequently diminishing trans-cutaneous vita-
min D absorption. We had a negative linear correlation
between fasting blood glucose levels and vitamin D3. OurFigure 1 The scatter plot shows negative linear correlation between ffindings also support an independent inverse association
between 25(OH)D and HbA1c in women with GDM,
showing a potential interaction between 25(OH)D and
blood glucose control in pregnancy. The higher levels of
HbA1c, indicating poor glycemic control, were found in
women with lower levels of 25(OH)D and this inverse re-
lation was found to be statistically significant (r = - 0.492).
The possible explanation for such relationship, be-
tween Vitamin D deficiency and the impaired glycemic
control, found in our study could be made attributed to
the defect in the important role that Vitamin D plays in
glucose homeostasis, and via different mechanisms. The
mechanism of action of vitamin D in type 2 diabetes is
thought to be mediated not only through regulation of
plasma calcium levels, which regulate insulin synthesis
and secretion, but it also improves insulin sensitivity of
the target cells (liver, skeletal muscle, and adipose tissue).
Additionally, Vitamin D enhances and improves β-cell
function and protects them from detrimental immune at-
tacks, directly by its action on β-cells, but also indirectly
by acting on different immune cells, including inflamma-
tory macrophages, dendritic cells, and a variety of T cells.
Macrophages, dendritic cells, T lymphocytes, and B lym-
phocytes can synthesize Vitamin D, all contributing to the
regulation of local immune responses [15].
This correlation between vitamin D and GDM were eval-
uated by various studies and the results were controversial
[16-19]. Maghbooli et al demonstrated that maternal serum
levels of 25(OH)D during 24-28 weeks of pregnancy were
significantly lower in women with GDM compared with
controls [16]. More recently, Makgoba and his colleaguesasting blood glucose and Vitamin D level (r = - 0.245).
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serum 25(OH)D levels and subsequent GDM development
[17]. On the other way round, Clifton-Bligh demonstrated
an inverse association between maternal serum 25(OH)D
levels and fasting blood glucose, although the association
between 25(OH)D and GDM was not statistically signifi-
cant [18]. Additionally, a recent study of Indian women
failed to demonstrate a relationship between maternal vita-
min D status and risk of developing GDM [19]. More re-
cently meta-analysis, published in 2013, linked gestational
diabetes with insufficient 25(OH)D levels, it correlated in
addition vitamin D deficiency to preeclampsia, preterm
birth and small for gestational age (SGA) babies [20]. In
2013, a randomized controlled study from a Turkish group,
on 234 women with GDM and 168 controls, came to a
more specific conclusion; they found a statistical signifi-
cance, between glycemic control and vitamin D levels, only
in women with severe deficiency of 25(OH)D levels. They
also concluded that only this group (with severe vitamin D
deficiency) is at a higher risk of GDM [21]. We mostly attri-
bute this disparity in the results and correlations to the
population differences, the most influential factor being,
from our point of view, the absence or very few numbers of
pregnant women with severely deficient 25OHD.
An important limitation of the present study is the
small number of patients with severe vitamin D defi-
ciency and the single measurement of 25(OH)D levels
in the third trimester of pregnancy. Other confounding
factors included the seasonal variation, as the study ex-
tended over a whole year, the heterogeneity of dietary
habits and the differences in socioeconomic standards
between the included pregnant women. We believe
however that these factors did not have a major impact
on the statistical analysis of this study, considering that
most, if not all, of our patients live in the poor socioeco-
nomic areas.
Conclusions
In our study, there was high prevalence of vitamin D in-
sufficiency and deficiency. Considering this we suggest
routine testing of all pregnant women, and treatment of
women who are found to be vitamin D deficient. We do
not know whether adequate vitamin D replacement may
contribute to prevention of GDM later in pregnancy, as
our study suggests a significant inverse correlation be-
tween vitamin D status and glycemic control in all the
pregnant women included. We recommend larger scale
studies addressing this issue, with a special concern to
the effectiveness of adequate replacement of vitamin D
in preventing GDM.
Abbreviations
GDM: Gestational diabetes mellitus; BMI: Body mass index;
Quicki: Quantitative insulin sensitivity check index; NHANES: National health
and nutrition examination survey; S: Significant; NS: Not significant.Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
All authors have contributed sufficiently to the work. AEL provided the idea
of the study, shared in the study design and data collection and results
interpretation. RMA shared in data collection and was responsible for the
preliminary editing, language review and statistical correlation. YME shared in
the study design and was responsible for the final editing and submission
processes. AMS revised the scientific material. RMAS was responsible for the
diabetes control part of the study and provided scientific material. All
authors read and approved the final manuscript.
Acknowledgment
We wish to thank the department of Clinical Pathology, Cairo University, for
their cooperation with us in performing the blood tests.
Author details
1Obstetrics and Gynecology Department, Cairo University, Cairo, Egypt.
2General Medicine Departments, Cairo University, Cairo, Egypt.
Received: 1 June 2014 Accepted: 6 October 2014
Published: 13 October 2014
References
1. Lapillonne A: Vitamin D, deficiency during pregnancy may impair
maternal and fetal outcomes. Med Hypotheses 2010, 74(1):71–75.
2. Bezerra FF, Laboissiere FP, King JC, Donangelo CM: Pregnancy and
lactation affect markers of calcium and bone metabolism differently in
adolescent and adult women with low calcium intakes. J Nutr 2002,
132:2183–2187.
3. Luong K, Nguyen LTH, Nguyen DNP: The role of vitamin D in protecting
type 1 diabetes mellitus. Diabetes Metab Res Rev 2005, 21:338–346.
4. Lau SL, Gunton JE, Athayde NP, Byth K, Cheung NW: Serum 25-hydroxyvitamin
D and glycated haemoglobin levels in women with gestational diabetes
mellitus. Med J Aust 2011, 194(7):334–337.
5. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A:
Correlation of glucose regulation and hemoglobin A1c in diabetes
mellitus. N Engl J Med 1976, 295:417–420.
6. American College of Endocrinology: Consensus statement on guidelines
for glycemic control. Endocrine Pract 2002, 8:5–11.
7. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ:
Quantitative insulin sensitivity check index: a simple, accurate method
for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000,
85(7):2402–2410.
8. Heaney RP: Vit D, in health and disease. Clin JAM Soc Nephrol 2008,
3(5):1535–1541.
9. Perez-Lopez FR, Chedraui P, Fernandez-Alonso AM: vit D and aging:beyond
calcium and bone metabolism. Maturitas 2011, 69(1):27–36.
10. Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B: Glucose
intolerance in pregnancy and future risk of pre-diabetes or diabetes.
Diabetes Care 2008, 31(10):2026–2031.
11. Johnson JA, Grande JP, Roche PC, Kumar R: Immunohistochemical
localization of the 1,25(OH)2D3 receptor and calbindin D28k in human
and rat pancreas. Am J Physiol 1994, 267(3 Pt 1):E356–E360.
12. Soskić S, Stokić E, Isenović ER: The relationship between vitamin D and
obesity. Curr Med Res Opin 2014, 30(6):1197–1199. doi:10.1185/
03007995.2014.900004. Epub 2014 Mar 18.
13. Drincic A, Fuller E, Heaney RP, Armas LA: 25-Hydroxyvitamin D response to
graded vitamin D₃ supplementation among obese adults. J Clin
Endocrinol Metab 2013, 98(12):4845–4851. doi:10.1210/jc.2012-4103.
Epub 2013 Sep 13.
14. The National Health and Nutrition Examination Survey 2003/2004.
http://wwwn.cdc.gov/nchs/nhanes/search/nhanes03_04.aspx.
15. Chih-Chien S, Min-Tser L, Kuo-Cheng L, Chia-Chao W: Role of Vitamin D in
Insulin Resistance. J Biomed Biotechnol 2012, 2012: Article ID 634195,
11 pages. http://dx.doi.org/10.1155/2012/634195.
16. Maghbooli Z, Hossein-Nezhad A, Karimi F, Shafaei AR, Larijani B: Correlation
between vitamin D3 deficiency and insulin resistance in pregnancy.
Diabetes Metab Res Rev 2008, 24(1):27–32.
El Lithy et al. BMC Pregnancy and Childbirth 2014, 14:362 Page 6 of 6
http://www.biomedcentral.com/1471-2393/14/36217. Makgoba M, Nelson SM, Savvidou M, Messow CM, Nicolaides K, Sattar N:
First-trimester circulating 25-hydroxyvitamin D levels and development
of gestational diabetes mellitus. Diabetes Care 2011, 34(5):1091–1093.
18. Clifton-Bligh RJ, McElduff P, McElduff A: Maternal vitamin d deficiency,
ethnicity and gestational diabetes. Diabet Med 2008, 25(6):678–684.
19. Farrant HJ, Krishnaveni GV, Hill JC, Boucher BJ, Fisher DJ, Noonan K,
Osmond C, Veena SR, Fall CH: Vitamin D insufficiency is common in
Indian mothers but is not associated with gestational diabetes or
variation in newborn size. Eur J Clin Nutr 2009, 63(5):646–652.
20. Wei SQ, Qi HP, Luo ZC, Fraser WD: Maternal vitamin D status and adverse
pregnancy outcomes: a systematic review and meta-analysis. J Matern
Fetal Neonatal Med 2013, 26(9):889–899.
21. Zuhur SS, Erol RS, Kuzu I, Altuntas Y: The relationship between low
maternal serum 25-hydroxyvitamin D levels and gestational diabetes
mellitus according to the severity of 25-hydroxyvitamin D deficiency.
Clinics (Sao Paulo) 2013, 68(5):658–664. doi:10.6061/clinics/2013(05)13.
doi:10.1186/1471-2393-14-362
Cite this article as: El Lithy et al.: The relationship between low
maternal serum vitamin D levels and glycemic control in gestational
diabetes assessed by HbA1c levels: an observational cross-sectional
study. BMC Pregnancy and Childbirth 2014 14:362.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
